ViewRay Systems, Inc. Stock

Stocks

Delayed OTC Markets 19:12:23 21/08/2026 +03			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

01-12	Outset Medical, Inc. Announces Board Changes	CI
12-03	Cowealth Medical China Unit to Sell Therapy System to Connected Party in Taiwan	MT

01-12	Outset Medical, Inc. Announces Board Changes	CI
12-03	Cowealth Medical China Unit to Sell Therapy System to Connected Party in Taiwan	MT
12/03/24	Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products	MT
26/10/23	Motion For Case Conversion Approved for ViewRay, Inc.	CI
12/10/23	Motion for Case Conversion Filed by ViewRay, Inc.	CI
29/08/23	Final DIP Financing Approved for ViewRay, Inc.	CI
23/08/23	Bidding Procedure Approved for ViewRay, Inc.	CI
03/08/23	On August 3, 2023, Viewray, Inc. Relocates Its Headquarters to Oakwood Village, Ohio	CI
25/07/23	ViewRay, Inc.(OTCPK:VRAY.Q) dropped from NASDAQ Composite Index	CI
21/07/23	ViewRay to be Delisted From Nasdaq July 26	MT
21/07/23	Insider Sell: Viewray	MT
21/07/23	ViewRay, Inc. Announces the Resignation of Sai Nanduri as Observer to the Board	CI
21/07/23	Motion for Asset Sale Filed by ViewRay, Inc.	CI

11/05/23	Morgan Stanley Adjusts ViewRay's Price Target to $1 From $2, Keeps Equalweight Rating	MT
11/05/23	B. Riley Downgrades ViewRay to Neutral From Buy, Notes More Cautious, Conservative 2023 Outlook; Trims PT to $1 From $4	MT
24/04/23	Piper Sandler Cuts Price Target on ViewRay to $2 From $6.50, Maintains Overweight Rating	MT
17/04/23	Jefferies Downgrades ViewRay to Hold From Buy, Cuts Price Target to $1.25 From $7	MT
14/04/23	Oppenheimer Downgrades ViewRay to Perform Rating From Outperform	MT

16/10/23	TeamBest Global Companies - Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies	AQ
21/07/23	ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets	PR
17/07/23	ViewRay® Files Voluntary Chapter 11 Petitions	PR
30/06/23	ViewRay : Failure to Satisfy Listing Rule - Form 8-K	PU
13/06/23	VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System	PR

Manager	Title	Age	Since
Samantha Pfeil SAM	Sales & Marketing	-	01/04/2021
Amanda Sequira LAW	General Counsel	49	01/10/2018

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/21/23 A	B. Johnson	Sell	Director	30,702	0.0167%
7/19/23 A	Kearny Venture Partners	Sell	Company	1,545,600	0.8427%
7/19/23 A	Karen Prange	Sell	Director	129,466	0.0706%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIEWRAY SYSTEMS, INC.	0.00%	0.00%	-	-	183
CHURCHILL CAPITAL CORP XI	+3.52%	-14.47%	-	-	784M
CENTIEL AG	-7.45%	-7.18%	+289.16%	-70.90%	713M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.20%	+0.10%	-	-	646M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.39%	+0.29%	-	-	603M
CHURCHILL CAPITAL CORP XII	-0.74%	-0.33%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	-0.48%	-0.77%	-	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.99%	+1.39%	-	-	575M
CHURCHILL CAPITAL CORP XIII	+0.10%	-0.85%	-	-	508M
Average	-0.51%	-1.59%	+289.16%	-70.90%	557.94M
Weighted average by Cap.	-0.59%	-2.22%	+289.16%	-70.90%